heart disease, and it has been postulated that a polypill might be developed to maximise the benefit and adherence. 4 What is less clear is whether the use of multiple drug regimens in general practice has any beneficial or detrimental effects on overall health at the population level, and specifically in relation to change over a longer-term time period.
INTRODUCTION
One of the key interventions in reduction of disease risk and progression are drug therapies. Polypharmacy in general practice is high, 1 especially in older populations, and routine drug use has been further formalised by chronic disease management approaches. These changes have been part of the larger public health initiative aimed at the reduction of disease-specific complications and mortality, but there have been few attempts at investigating the overall health benefits of multiple drug therapies in older populations. 2, 3 There has also been scientific debate in relation to the implications of multiple drug treatments in the management of chronic disease such as ischaemic hierarchical structure, which details different drugs for the same disease indication or for different classes of drugs within the specific body system. 6 The definition of multidrug therapy was based on overall counts at the second hierarchy by: 'number of drugs prescribed for an individual including different drugs for the same disease, but not including repeat prescription for the same drug in the same time period'.
Statistical analyses
Baseline survey measures of health, using the respective study population mean values, were dichotomised SF-12 scores for physical and psychological health. Baseline drug counts in the 2-year time period before the survey were dichotomised about the mean and in the 3-year follow-up period counts were categorised into four groups: (i) 1 to 4 prescribed drugs; (ii) 5 to 7 drugs; (iii) 8 to 11 drugs; and (iv) 12 drugs and over. Associations between the four categories of overall drug counts and the three health-change case groups compared to controls were separately assessed using logistic regression methods with 95% confidence intervals (CIs).
RESULTS
There was a significant and increasing strength of association between higher drug counts and worse physical and psychological health compared to the lowest counts group (trend P<0.001). The adjusted figures were: category two, odds ratio (OR) 1.55 (95% CI = 1.2 to 2.1); category three, OR 2.25 (95% CI = 1.7 to 3.1); and category four, OR 2.91 (95% CI = 2.0 to 4.2).
There was a significant and increasing strength of association between higher drug counts and worse physical health compared to the lowest counts group (trend P = 0.025). The adjusted figures were: category two, OR 1.24 (95% CI = 0.97 to 1.6); category three, OR 1.42 (95% CI = 1.1 to 1.9); and category four, OR 1.64 (95% CI = 1.2 to 2.3) ( Table 2) .
While the strength of association between higher drug counts and worse psychological health increased (but was weaker), it did not show any significant statistical trend.
DISCUSSION

Summary of main findings
There were high levels of multiple drugs routinely prescribed in the older population of individuals aged ≥50 years from general practice, but such high prescribing was not associated with benefit as measured by change in physical and psychological health over a 3-year time period. Therefore, the possible implications that are generated from these results are either that multidrug therapy may be detrimental to health or that there was an increased
How this fits in
Multiple drugs prescribing in general practice populations is high, but whether this benefits overall health is unknown. Higher levels of drug prescribing were associated with deterioration in physical and combined physical and psychological health. The study highlights the potential need for assessing prescribing in terms of overall health. 
Brief Reports
Strengths and limitations of the study
In terms of testing a hypothesis, this study was drawn from a large population-based cohort and provides an internal comparison (and 'dose'-relationship) of multidrug counts and its association with health change. The simple drug counts measure does not convey the indication or duration of drug therapies, and whether they were aimed at short-term conditions (for example, antibiotics for infections) or for chronic diseases on an ongoing basis (for example, diabetes or ischaemic heart disease). This approach also does not disentangle the specific drug interactions or adherence issues that might play different roles in influencing health change.
7,8
Comparison with existing literature
Previous studies indicate that psychological distress is associated with increased comorbidity, 9 and so is likely to be associated with a higher number of prescribed drug therapies. However, the analyses for the group whose psychological health worsened showed that the prescribing response was relatively weaker than for the other two groups. Clinical practitioners also usually prescribe in response to disease diagnosis or symptoms, as opposed to health change, 10 and this further indicates the need for a prospective investigation into the effect of multiple drug therapy on long-term health change.
Implications for clinical practice
In conclusion, the study shows that multidrug therapy was associated with worse physical health or combined physical and psychological health over a 3-year period. Baseline health or drug prescribing, or sociodemographic characteristics did not explain these results. The importance of the study findings then relates to whether prescribing should be assessed in terms of overall health assessment or whether multipharmacy should be simply viewed as benefiting specific illness or disease management.
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